After an 80-year gap, human trials of a new tuberculosis vaccine are due to
start. If the vaccine is successful it could save millions of lives each year.
TB jabs use a weakened form of the bacterium that causes the disease in
cows—Bacille Calmette-Guérin. BCG gives good protection for about
10 years but then it wears off, and booster shots have little effect. Now Helen
McShane at the John Radcliffe Hospital in Oxford is starting trials with a
modified cowpox virus that carries a TB antigen. Used as a booster after BCG,
the new vaccine should give a…
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
2
Electric vehicle owners could earn thousands by supporting power grid
3
Neanderthal infants were enormous compared with modern humans
4
How autoimmune conditions can unexpectedly drive mental illness
5
The biggest threat to Chernobyl is no longer radiation
6
You can now buy a DIY quantum computer
7
The first quantum computer to break encryption is now shockingly close
8
The profound effect the heart-brain connection has on your health
9
Largest ever map of universe captures 47 million galaxies and quasars
10
A key solution to climate change isn't happening – and that's good
